158 related articles for article (PubMed ID: 34504274)
1. Pharmacological inhibition of cryptochrome and REV-ERB promotes DNA repair and cell cycle arrest in cisplatin-treated human cells.
Anabtawi N; Cvammen W; Kemp MG
Sci Rep; 2021 Sep; 11(1):17997. PubMed ID: 34504274
[TBL] [Abstract][Full Text] [Related]
2. Circadian control of XPA and excision repair of cisplatin-DNA damage by cryptochrome and HERC2 ubiquitin ligase.
Kang TH; Lindsey-Boltz LA; Reardon JT; Sancar A
Proc Natl Acad Sci U S A; 2010 Mar; 107(11):4890-5. PubMed ID: 20304803
[TBL] [Abstract][Full Text] [Related]
3. A synthetic cryptochrome inhibitor induces anti-proliferative effects and increases chemosensitivity in human breast cancer cells.
Chun SK; Chung S; Kim HD; Lee JH; Jang J; Kim J; Kim D; Son GH; Oh YJ; Suh YG; Lee CS; Kim K
Biochem Biophys Res Commun; 2015 Nov; 467(2):441-6. PubMed ID: 26407844
[TBL] [Abstract][Full Text] [Related]
4. [Enhancement effect of nucleotide excision repair gene xeroderma pigmentosun group a antisense RNA on sensitivity of human lung adenocarcinoma cell line A549 to cisplatin].
Fan W; Zhang HL; Wu XM
Ai Zheng; 2005 Apr; 24(4):403-7. PubMed ID: 15820060
[TBL] [Abstract][Full Text] [Related]
5. Identification of SR8278, a synthetic antagonist of the nuclear heme receptor REV-ERB.
Kojetin D; Wang Y; Kamenecka TM; Burris TP
ACS Chem Biol; 2011 Feb; 6(2):131-4. PubMed ID: 21043485
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of REV-ERBs stimulates microglial amyloid-beta clearance and reduces amyloid plaque deposition in the 5XFAD mouse model of Alzheimer's disease.
Lee J; Kim DE; Griffin P; Sheehan PW; Kim DH; Musiek ES; Yoon SY
Aging Cell; 2020 Feb; 19(2):e13078. PubMed ID: 31800167
[TBL] [Abstract][Full Text] [Related]
7. ATR kinase inhibition sensitizes quiescent human cells to the lethal effects of cisplatin but increases mutagenesis.
Hutcherson RJ; Kemp MG
Mutat Res; 2019 Nov; 816-818():111678. PubMed ID: 31557599
[TBL] [Abstract][Full Text] [Related]
8. The involvement of ataxia-telangiectasia mutated protein activation in nucleotide excision repair-facilitated cell survival with cisplatin treatment.
Colton SL; Xu XS; Wang YA; Wang G
J Biol Chem; 2006 Sep; 281(37):27117-25. PubMed ID: 16849332
[TBL] [Abstract][Full Text] [Related]
9. New design of nucleotide excision repair (NER) inhibitors for combination cancer therapy.
Gentile F; Tuszynski JA; Barakat KH
J Mol Graph Model; 2016 Apr; 65():71-82. PubMed ID: 26939044
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Gli1 results in altered c-Jun activation, inhibition of cisplatin-induced upregulation of ERCC1, XPD and XRCC1, and inhibition of platinum-DNA adduct repair.
Kudo K; Gavin E; Das S; Amable L; Shevde LA; Reed E
Oncogene; 2012 Nov; 31(44):4718-24. PubMed ID: 22266871
[TBL] [Abstract][Full Text] [Related]
11. Involvement of the clock gene Rev-erb alpha in the regulation of glucagon secretion in pancreatic alpha-cells.
Vieira E; Marroquí L; Figueroa AL; Merino B; Fernandez-Ruiz R; Nadal A; Burris TP; Gomis R; Quesada I
PLoS One; 2013; 8(7):e69939. PubMed ID: 23936124
[TBL] [Abstract][Full Text] [Related]
12. A truncated human xeroderma pigmentosum complementation group A protein expressed from an adenovirus sensitizes human tumor cells to ultraviolet light and cisplatin.
Rosenberg E; Taher MM; Kuemmerle NB; Farnsworth J; Valerie K
Cancer Res; 2001 Jan; 61(2):764-70. PubMed ID: 11212280
[TBL] [Abstract][Full Text] [Related]
13. Artesunate Impairs Growth in Cisplatin-Resistant Bladder Cancer Cells by Cell Cycle Arrest, Apoptosis and Autophagy Induction.
Zhao F; Vakhrusheva O; Markowitsch SD; Slade KS; Tsaur I; Cinatl J; Michaelis M; Efferth T; Haferkamp A; Juengel E
Cells; 2020 Dec; 9(12):. PubMed ID: 33316936
[TBL] [Abstract][Full Text] [Related]
14. Increased levels of XPA might be the basis of cisplatin resistance in germ cell tumours.
Cierna Z; Miskovska V; Roska J; Jurkovicova D; Pulzova LB; Sestakova Z; Hurbanova L; Machalekova K; Chovanec M; Rejlekova K; Svetlovska D; Kalavska K; Kajo K; Babal P; Mardiak J; Ward TA; Mego M; Chovanec M
BMC Cancer; 2020 Jan; 20(1):17. PubMed ID: 31906898
[TBL] [Abstract][Full Text] [Related]
15. Late activation of stress-activated protein kinases/c-Jun N-terminal kinases triggered by cisplatin-induced DNA damage in repair-defective cells.
Helbig L; Damrot J; Hülsenbeck J; Köberle B; Brozovic A; Osmak M; Fiket Z; Kaina B; Fritz G
J Biol Chem; 2011 Apr; 286(15):12991-3001. PubMed ID: 21324906
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological targeting of the mammalian clock regulates sleep architecture and emotional behaviour.
Banerjee S; Wang Y; Solt LA; Griffett K; Kazantzis M; Amador A; El-Gendy BM; Huitron-Resendiz S; Roberts AJ; Shin Y; Kamenecka TM; Burris TP
Nat Commun; 2014 Dec; 5():5759. PubMed ID: 25536025
[TBL] [Abstract][Full Text] [Related]
17. Sensitization to the cytotoxicity of cisplatin by transfection with nucleotide excision repair gene xeroderma pigmentosun group A antisense RNA in human lung adenocarcinoma cells.
Wu X; Fan W; Xu S; Zhou Y
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5874-9. PubMed ID: 14676109
[TBL] [Abstract][Full Text] [Related]
18. Circadian clock, carcinogenesis, chronochemotherapy connections.
Yang Y; Lindsey-Boltz LA; Vaughn CM; Selby CP; Cao X; Liu Z; Hsu DS; Sancar A
J Biol Chem; 2021 Sep; 297(3):101068. PubMed ID: 34375638
[TBL] [Abstract][Full Text] [Related]
19. The Putatively Specific Synthetic REV-ERB Agonist SR9009 Inhibits IgE- and IL-33-Mediated Mast Cell Activation Independently of the Circadian Clock.
Ishimaru K; Nakajima S; Yu G; Nakamura Y; Nakao A
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31847374
[TBL] [Abstract][Full Text] [Related]
20. Cell cycle checkpoint abrogator UCN-01 inhibits DNA repair: association with attenuation of the interaction of XPA and ERCC1 nucleotide excision repair proteins.
Jiang H; Yang LY
Cancer Res; 1999 Sep; 59(18):4529-34. PubMed ID: 10493501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
